Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.
Stocks · News reference
Zimmer Biomet Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.